Uterine side effects of tamoxifen: a need for systematic pretreatment screening (original) (raw)

Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2007

Comparison of Endometrial Changes among Symptomatic Tamoxifen-Treated and Nontreated Premenopausal and Postmenopausal Breast Cancer Patients

Ho-hsiung Lin

Gynecologic Oncology, 1997

View PDFchevron_right

Endometrial changes in post-menopausal breast cancer patients on tamoxifen

Majedah Al-azemi

International Journal of Gynecology & Obstetrics, 2002

View PDFchevron_right

Hysteroscopic endometrial evaluation in postmenopausal women taking tamoxifen for breast cancer

Fiorino Marello

The Journal of the American Association of Gynecologic Laparoscopists, 1999

View PDFchevron_right

Tamoxifen-induced endometrial changes in postmenopausal women with breast carcinoma

Ruby Jose, Aruna Kekre

International Journal of Gynecology & Obstetrics, 2002

View PDFchevron_right

Spectrum of tamoxifen associated endometrial pathology in breast cancer patients

Farhan Aga

Journal of the Pakistan …, 2009

View PDFchevron_right

Endometrial histologic changes in post-menopausal breast cancer patients using tamoxifen

Lorenza Driul

International Journal of Gynecology & Obstetrics, 2001

View PDFchevron_right

Endometrial evaluation by ultrasonography, hysteroscopy and histopathology in cases of breast carcinoma on Tamoxifen therapy

risham singla

Journal of mid-life health

View PDFchevron_right

The potential oncogenic effect of tamoxifen on the endometrium

Martine Berliere

Human reproduction (Oxford, England), 1999

View PDFchevron_right

Baseline endometrial assessment before tamoxifen for breast cancer in asymptomatic menopausal women

Massimo Luerti

Gynecologic Oncology, 2005

View PDFchevron_right

Assessment of the Endometrium in Postmenopausal Breast Cancer Patients on Tamoxifen: An Ultrasound, Hystroscopic, Histopathlogical and Flow Cytometric Study

Mostafa Khaled

2003

View PDFchevron_right

Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial

Tom Bourne

Lancet, 1994

View PDFchevron_right

Ultrasonographic appearance of endometrium in postmenopausal breast cancer patients receiving tamoxifen

Nil Mandel

European Journal of Obstetrics & Gynecology and Reproductive Biology, 1996

View PDFchevron_right

Prevalence of Endometrial Proliferation in Pipelle Biopsies in Tamoxifen-Treated Postmenopausal Women with Breast Cancer in Kuwait

Labiba Temmim

Medical Principles and Practice, 2004

View PDFchevron_right

Ultrasonographic Appearance of the Uterine Endometrium in Sudanese Breast Cancer Women on Tamoxifen Therapy

randa salah

Journal of Womens Health Care, 2015

View PDFchevron_right

Relationship between tamoxifen use and high risk endometrial cancer histologic types

Fidel Valea

Gynecologic Oncology, 2009

View PDFchevron_right

Significance and prevalence of Tamoxifen related endometrial changes in patients of carcinoma breast

IJSRP Journal

View PDFchevron_right

A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience

Georgios Androutsopoulos, DIMITRIOS KARDAMAKIS

Breast J, 2006

View PDFchevron_right

Tamoxifen-induced endometrial carcinoma after a lag of 14 years

Rajeev Sen

South Asian Journal of Cancer, 2013

View PDFchevron_right

Endometrial polyp surveillance in premenopausal breast cancer patients using tamoxifen

Yong Song

Obstetrics & gynecology science, 2017

View PDFchevron_right

Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630

Garnet Anderson

npj Breast Cancer, 2016

View PDFchevron_right

Title Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer : SWOG S 9630

Caryl Salomon

2016

View PDFchevron_right

Retrospective analysis of hysteroscopic findings in breast cancer patients having adjuvant tamoxifen treatment

Burak Zeybek

European journal of gynaecological oncology, 2010

View PDFchevron_right

Hysteroscopically Targeted Biopsies Compared with Blind Samplings in Endometrial Assessment of Menopausal Women Taking Tamoxifen for Breast Cancer

Massimo Luerti

The Journal of the American Association of Gynecologic Laparoscopists, 2004

View PDFchevron_right

Histopathologic effects of tamoxifen on the uterine epithelium of breast cancer patients: analysis by menopausal status

Dr Steven A Vasilev MD

Cancer Letters, 1996

View PDFchevron_right

Uterine effects of tamoxifen: a prospective study

Dr Steven A Vasilev MD

International Journal of Gynecological Cancer, 2006

View PDFchevron_right

Discrepancy between Ultrasonography and Hysteroscopy and Histology of Endometrium in Postmenopausal Breast Cancer Patients Using Tamoxifen

Harry Hollema, Marian J.e Mourits

Gynecologic Oncology, 1999

View PDFchevron_right

Risk of Endometrial Cancer After Tamoxifen Treatment of Breast Cancer

Harm van Tinteren

Obstetrical & Gynecological Survey, 1994

View PDFchevron_right

Surveillance for Endometrial Cancer in Women on Tamoxifen: The Role of Liquid-Based Endometrial Cytology – Cytohistological Correlation in a Population of 168 Women

Francesca Garbini

Gynecologic and Obstetric Investigation, 2008

View PDFchevron_right

Uterine side effects of tamoxifen: a need for systematic pretreatment screening (original) (raw)

Related papers